COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,399 Articles (22,816 medRxiv, 8,583 bioRxiv)

Most recent first Previous |  Page 780: Articles 7791-7800  | Next

A Model-Based Strategy on COVID-19 Vaccine Roll-out in the Philippines
Escosio, R. A. S., Cawiding, O. R., Hernandez, B. S., Mendoza, R. G., Mendoza, V. M. P., Mohammad, R. Z., Pilar-Arceo, C. P. C., Salonga, P. K. N., Suarez, F. L. E., Sy, P. W., Vergara, T. H. M., de los Reyes, A. A.
10.1101/2022.05.27.22275675 — Posted: 2022-05-27
The Glycan-Specificity of the Pineapple Lectin AcmJRL and its Carbohydrate-Dependent Binding of the SARS-CoV-2 Spike Protein
Meiers, J., Dastbaz, J., Adam, S., Rasheed, S., Kirsch, S. H., Meiser, P., Gross, P., Mueller, R., Titz, A.
10.1101/2022.05.27.493400 — Posted: 2022-05-27
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages
Li, X., Pan, Y., Yin, Q., Wang, Z., Shan, S., Zhang, L., Yu, J., Qu, Y., Sun, L., Gui, F., Lu, J., Jing, Z., Wu, W., Huang, T., Shi, X., Li, J., Li, X., Li, D., Wang, S., Yang, M., Zhang, L., Duan, K., Liang, M., Yang, X., Wang, X.
10.1101/2022.05.27.493682 — Posted: 2022-05-27
Development and scaling of a sequencing pipeline for genomic surveillance of SARS-CoV-2 in New York City
Hammerling, M. J., Kang, S. C., Ward, W., Escapa, I. F., Bugga, P., Del Castillo, C., Hopkins, M., Chase, S., Rey, S., Law, D., Carpio, A., Nelson, K., Chhabria, S., Gupta, S., Rivera, T., Laurent, J. M., Hao, H., Lee, H. H.
10.1101/2022.05.25.22273991 — Posted: 2022-05-27
Pseudotemporal whole blood transcriptional profiling of COVID-19 patients stratified by clinical severity reveals differences in immune responses and possible role of monoamine oxidase B
Broderick, C., Rivero Calle, I., Gomez Carballa, A., Gomez-Rial, J., Li, H. K., Mehta, R., Jackson, H., Salas, A., Martinon-Torres, F., Sriskandan, S., Levin, M., Kaforou, M., BioAID Consortium, , GEN-COVID Study Group
10.1101/2022.05.26.22274729 — Posted: 2022-05-27
Antigen testing for COVID-19 using image-based assessment of oral specimens
Shimozono, S., Sugiyama, M., Kurokawa, H., Hama, H., Sato, M., Morikawa, S., Kuwana, K., Haga, K., Takai-Todaka, R., Inaura, S., Matsumura, Y., Masaki, H., Nemoto, N., Ando, R., Kogure, T., Tosaki, A., Fukuyama, H., Saya, H., Nakagawa, T., Morimoto, T., Nishihara, H., Katayama, K., Miyawaki, A.
10.1101/2022.05.27.22274752 — Posted: 2022-05-27
A hospital-based study to assess various biomarkers for prognostic prediction of clinical outcome in COVID-19 disease.
Padhi, A., Shaw, D., Khatoon, S., Ranjan, S., Bhargava, A., Negi, S. S.
10.1101/2022.05.25.22275583 — Posted: 2022-05-27
Pilot study to evaluate hypercoagulation and inflammation using rotational thromboelastometry and calprotectin in COVID-19 patients.
Roy, A., Stanford, S., Rea, C., Harris, B., Ashton, A., Mangles, S., Everington, T., Taher, R., Burns, D., Arbuthnot, E., Cecil, T.
10.1101/2022.05.27.22275701 — Posted: 2022-05-27
Impact of the COVID-19 pandemic on Latino families with Alzheimer's disease and related dementias: Perceptions of family caregivers and primary care providers
Perales-Puchalt, J., Peltzer, J., Fracachan-Cabrera, M., Perez, A. G., Ramirez-Mantilla, M., Greiner, K. A., Burns, J. M.
10.1101/2022.05.25.22275517 — Posted: 2022-05-27
Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery
Milazzo, F. M., Chaves-Sanjuan, A., Minenkova, O., Santapaola, D., Anastasi, A. M., Battistuzzi, G., Chiapparino, C., Rosi, A., Merlo Pich, E., Albertoni, C., Marra, E., Luberto, L., Viollet, C., Spagnoli, L. G., Riccio, A., Rossi, A., Santoro, M. G., Ballabio, F., Paissoni, C., Camilloni, C., Bolognesi, M., De Santis, R.
10.1101/2022.05.27.493569 — Posted: 2022-05-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).